This clinical trial aims to evaluate if nano-hydroxyapatite (Nano-HA) toothpaste effectively treats children with Molar-Incisor Hypomineralization (MIH). It will also assess the safety of Nano-HA toothpaste. The main questions are:
* Does Nano-HA toothpaste reduce caries incidence, improve tooth aesthetics, and decrease hypersensitivity? * How does Nano-HA compare to fluoridated toothpaste in terms of outcomes?
Participants will:
* Use Nano-HA or fluoridated toothpaste daily for 12 months. * Visit the clinic for checkups and evaluations every 1 to 3 months. * Record symptoms, brushing compliance, and sensitivity.
The study will compare Nano-HA toothpaste to fluoridated toothpaste to determine its efficacy in managing MIH .
Diagnosed with Molar-Incisor Hypomineralization (MIH) in at least one first permanent molar or hypomineralization of a second primary molar (HSPM).
Presence of white, creamy, yellow, or brown demarcated opacities
Indexed teeth include permanent first molars and permanent maxillary incisors.
• Decayed permanent molars.
Diabetes, hypertension, sleeping disorders, or allergic reactions to medications.
Children on medication
Presence of other enamel defects (e.g., fluorosis, amelogenesis imperfecta, enamel hypoplasia, or white spot lesions).